非高危胃癌腹腔镜辅助胃切除术后无管ERAS策略的可行性
这项前瞻性非随机对照研究在高容量中心纳入无高危特征的胃癌患者,按1:1分配至ERAS-无管组或ERAS-有管组,比较术后住院时间和生活质量等结局。结果显示无管组平均术后住院时间更短(6.0 vs. 7.3天,P<0.001),术后第1、3天QoR-15评分更高,早期并发症未增加,但研究效能不足以排除罕见严重不良事件。
要点
- 非高危胃癌腹腔镜辅助胃切除术后采用无管ERAS策略可缩短术后住院时间。
- 无管策略与术后第1、3天QoR-15评分更高相关,患者体验改善。
- 早期并发症未增加,但研究不足以排除罕见严重不良事件。
核心结论
- 在严格手术质量控制下,非高危胃癌患者腹腔镜辅助胃切除术后实施ERAS-无管策略可促进术后恢复、改善患者体验,且不增加早期并发症风险,但仍需进一步验证。
研究设计与样本
- 前瞻性非随机对照研究,在高容量中心纳入cT1-4N0-3M0且无方案定义高危特征的胃癌患者,按团队级分配方案以1:1预定义比例分配至ERAS-无管组或ERAS-有管组。
- 2023年3月至2024年9月共分配220例患者,排除后符合方案人群205例。
- 所有患者均遵循严格一致的质量控制标准行腹腔镜辅助胃切除术,并接受不同的ERAS术后管路管理策略。
- 主要结局为术后住院时间,次要结局包括术后生活质量评分和并发症发生率。
主要发现
- ERAS-无管组平均术后住院时间短于ERAS-有管组(6.0 vs. 7.3天;P < 0.001)。
- 经Benjamini-Hochberg多重比较校正后,QoR-15评分在术后第1天和第3天仍显著更高。
- EORTC QLQ-C30中,总体健康与生活质量、情绪功能和社会功能领域组间差异持续存在。
- 未观察到早期术后并发症发生率增加,但研究效能不足以排除罕见但严重的不良事件。
临床怎么用
- 对于无方案定义高危特征的胃癌患者,在腹腔镜辅助胃切除术后可考虑实施无管ERAS策略以促进恢复。
- 实施无管策略需在严格手术质量控制体系下进行,并关注术后生活质量改善。
- 因研究不足以排除罕见严重不良事件,临床推广时仍需谨慎监测。
局限性
- 研究为非随机对照设计,可能存在选择偏倚。
- 研究效能不足以排除罕见但严重的不良事件。
- 结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although nasogastric decompression, nasojejunal feeding, and abdominal drainage tubes are not routinely recommended in Enhanced Recovery After Surgery (ERAS) guidelines for gastrectomy, evidence regarding the avoidance of any inserted tubes after laparoscopic gastrectomy remains limited. This study aimed to evaluate the short-term feasibility and clinical outcomes of an ERAS-tubeless protocol in gastric cancer patients undergoing non-high-risk laparoscopy-assisted gastrectomy. METHODS: At a high-volume center, eligible patients of gastric cancer (cT1-4N0-3M0) who lacked protocol-defined high-risk features were enrolled in this prospective non-randomized controlled study. Patients were allocated to either the ERAS-tubeless group or the ERAS-tube group at a predefined 1:1 ratio according to a team-level allocation protocol. All patients underwent laparoscopy-assisted gastrectomy following strict and consistent quality control standards and received distinct ERAS-based postoperative tube-management strategies. The primary outcome was postoperative hospital stay, and secondary outcomes included postoperative quality of life scores and the incidence of complications. RESULTS: Between March 2023 and September 2024, 220 patients were allocated, and 205 were included in the per-protocol population after post-allocation exclusions. The ERAS-tubeless group had a shorter mean postoperative hospital stay (6.0 vs. 7.3 days; P < 0.001). After Benjamini-Hochberg adjustment for multiple comparisons, QoR-15 scores remained significantly higher on postoperative days 1 and 3. For the EORTC QLQ-C30, significant between-group differences persisted in global health and QoL, emotional functioning, and social functioning domains. No increase in the incidence of early postoperative complications was observed; however, the study was underpowered to exclude rare but serious adverse events. CONCLUSIONS: In non-high-risk patients with gastric cancer, implementation of the ERAS-tubeless strategy following laparoscopy-assisted gastrectomy under a rigorous surgical quality control system can facilitate postoperative recovery, enhance patient experience, and not increase the risk of early postoperative complications, which warrants further validation.
引用
- Zhang G, Zhou H, Yu H, et al. Feasibility of a tubeless enhanced recovery strategy in non-high-risk patients undergoing laparoscopy-assisted gastrectomy for gastric cancer. Surg Endosc. 2026. PMID: 42864454. doi:10.1007/s00464-026-13467-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。